Phase III study: docetaxel (Taxotere) beat erlotinib in EGFR wild-type lung cancer: #ASCO2012: http://bit.ly/Mm2u3t
9:56 AM - 18 Jun 2012
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.